SFX by Ex Libris Inc.

Title:	Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1
Source:	Nature [0028-0836] Lim, J yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Koelsche, C. "CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas." Acta neuropathologica 123.6 (2012): 853-860.
description	2.	Bowman, Aaron B B. "Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes." Nature genetics 39.3 (2007): 373-9.
description	3.	Watase, K. "Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model." PLoS medicine 4.5 (2007): 836-847.
description	4.	Zoghbi, M. "The story of Rett syndrome: from clinic to neurobiology." Neuron 56.3 (2007): 422-37.
description	5.	Thompson, L. "Neurodegeneration: A question of balance." Nature 452.7188 (2008): 707-708.
description	6.	Sirvent, N. "Fusion of EWSR1 with the DUX4 facioscapulohumeral muscular dystrophy region resulting from t(4;22)(q35;q12) in a case of embryonal rhabdomyosarcoma." Cancer genetics and cytogenetics 195.1 (2009): 12-18.
description	7.	Zoghbi, H Y Y. "Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2." Nature genetics 23.2 (1999): 185-8.
description	8.	Geng, Linda N. "DUX4 Activates Germline Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral Dystrophy." Developmental cell 22.1 (2011): 38-51.
description	9.	Kinzler, D. "Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma." Science 333.6048 (2011): 1453-1455.
description	10.	Yip, S. "Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers." The Journal of pathology 226.1 (2012): 7-16.
description	11.	Chi, Andrew S. "Prospective, high-throughput molecular profiling of human gliomas." Journal of neuro-oncology 110.1 (2012): 89-98.
description	12.	Iwamoto, Fabio M M. "Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas." Journal of neuro-oncology 88.3 (2008): 293-8.
description	13.	Leonard, H. "Occurrence of Rett syndrome in boys." Journal of child neurology 16.5 (2001): 333-8.
description	14.	Zoghbi, Huda Y Y. "MeCP2 dysfunction in Rett syndrome and related disorders." Current opinion in genetics & development 16.3 (2006): 276-81.
description	15.	Lam, Yung C C. "ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology." Cell 127.7 (2007): 1335-47.
description	16.	Kang, S. "UbcH6 interacts with and ubiquitinates the SCA1 gene product ataxin-1." Biochemical and biophysical research communications 371.2 (2008): 256-60.
description	17.	Barroso-del Jesus, A. "The miR-302-367 cluster as a potential stemness regulator in ESCs." Cell cycle 8.3 (2009): 394-8.
description	18.	Williamson, Sarah L. "Rett syndrome: new clinical and molecular insights." European journal of human genetics 14.8 (2006): 896-903.
description	19.	JY, K. "Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy." Movement disorders 21.12 (2006): 2263-4.
description	20.	Subramony, P J S T. "Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1." Neuroscience Letters 420.1 (2007): 53-7.